MedTrace Logo

Plasmapheresis for Nephrogenic Fibrosing Dermopathy (NFD)/Nephrogenic Systemic Fibrosis (NSF)

NCT01078987 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2014-11-21

No results posted yet for this study

Summary

The purpose of this study is to evaluate the pathophysiology of nephrogenic fibrosing dermopathy (NFD)/nephrogenic systemic fibrosis (NSF).

Conditions

  • Nephrogenic Fibrosing Dermopathy
  • Nephrogenic Systemic Fibrosis

Interventions

PROCEDURE

Plasmapheresis

A course of 5 daily treatments of plasma exchange (plasmapheresis) for one to three courses

Sponsors & Collaborators

  • Loma Linda University

    lead OTHER

Principal Investigators

  • Pedro Baron, MD · Loma Linda University Medical Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-02-28
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01078987 on ClinicalTrials.gov